Showing results (211-220 of 330) with videos related to

Sort By:
Pageof 33
Radiology|July 1, 1991
Stage B adenocarcinoma of the prostate: transrectal US and pathologic correlation of nonmalignant hypoechoic peripheral zone lesionsU M Hamper, S Sheth, P C Walsh, et al.
AJR. American Journal of Roentgenology|November 1, 1990
Carcinoma of the prostate: value of transrectal sonography in detecting extension into the neurovascular bundleU M Hamper, S Sheth, P C Walsh, et al.
The Journal of Urology|November 1, 1990
The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancerH B Carter, A W Partin, J I Epstein, et al.
The Journal of Urology|November 24, 1999
Can ploidy of prostate carcinoma diagnosed on needle biopsy predict radical prostatectomy stage and grade?D A Brinker, J S Ross, T A Tran, et al.
International Journal of Cancer|November 24, 1999
Nuclear morphometry predicts disease-free interval for clinically localized adenocarcinoma of the prostate treated with definitive radiation therapyM D Hurwitz, T L DeWeese, E S Zinreich, et al.
The Urologic Clinics of North America|November 1, 1993
Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 yearsA W Partin, C R Pound, J Q Clemens, et al.
Urology|October 1, 1993
Relationship between changes in prostate-specific antigen and prognosis of prostate cancerJ A Cadeddu, J D Pearson, A W Partin, et al.
Urology|November 1, 1996
Ability to predict biochemical progression using Gleason score and a computer-generated quantitative nuclear grade derived from cancer cell nucleiR W Veltri, M C Miller, A W Partin, et al.
The Journal of Urology|July 1, 1987
Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostateJ E Oesterling, C B Brendler, J I Epstein, et al.
Cancer|May 1, 1990
Advanced small cell carcinoma of the bladder. Successful treatment with combined radical cystoprostatectomy and adjuvant methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapyJ E Oesterling, C B Brendler, J K Burgers, et al.
Pageof 33